STEK.US Stemtech Corporation

Healthcare Pharmaceuticals USA Stocks
0.0001 USD
Close of Nov 17, 2026
Market cap
USD 300K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is STEK.US undervalued?

Graham number

The Graham number of Stemtech Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Stemtech Corporation fundamental analysis

No fundamental analysis for Stemtech Corporation yet.

Stemtech Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Stemtech Corporation

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its products under the RCM System,…

Full company profile